ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2025
Published Date: May 2019
|
Report Code: QYRE-Auto-0195
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Active Pharmaceutical Ingredients API Market Insights Forecast to 2025

Global Active Pharmaceutical Ingredients (API) Market Insights, Forecast to 2025

Code: QYRE-Auto-0195
Report
May 2019
Pages:125
QYResearch
Description
Table of Content
Tables & Figures
FEATURED COMPANIES
TEVA
Mylan NV
DSM
Aurobindo Pharma
Aspen
Novartis
BASF AG
Pfizer Inc
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
BASF

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW

 
The Active Pharmaceutical Ingredients (API) market was valued at US$ 63210 Million in 2019 and is projected to reach US$ 99230 Million by 2026, at a CAGR of 6.6% during the forecast period
 
An active ingredient (AI) is the ingredient in a pharmaceutical drug that is biologically active. The similar terms active pharmaceutical ingredient (API) and bulk active are also used in medicine, and the term active substance may be used for natural products. Some medication products may contain more than one active ingredient. The traditional word for the API is pharmacon or pharmakon which originally denoted a magical substance or drug.
 
The EMEA average price of Active Pharmaceutical Ingredients is in the decreasing trend, from 6695 USD/MT in 2012 to 5483 USD/MT in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
 
The classification of Active Pharmaceutical Ingredients includes synthetic APIs, biotech APIs, and the proportion of synthetic APIs in 2017 is about 85%, and the proportion is in decreasing trend from 2012 to 2017.
 
Active Pharmaceutical Ingredients is widely used in CNS, Cardiovascular, Genitourinary/Hormonal Drugs, Respiratory, Rheumatology, Diabetes, Oncology and other field. The most proportion of Active Pharmaceutical Ingredients is used for cardiovascular, and the proportion in 2017 is 21%.
 
In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Active Pharmaceutical Ingredients (API).
 
This report researches the worldwide Active Pharmaceutical Ingredients (API) market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
 
This study categorizes the global Active Pharmaceutical Ingredients (API) breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
 
The following manufacturers are covered in this report:
 
  • Teva
  • Mylan
  • DSM
  • Aurobindo Pharma
  • Aspen
  • Novartis
  • BASF
  • Pfizer
  • Huahai Pharmaceutical
  • Hisun Pharmaceutical
  • Sun Pharmaceutical Industries
  • Zhejiang Medicine
  • Dr. Reddy’s Laboratories
  • Zhejiang NHU
  • Bayer
  • NCPC
  • AbbVie
  • Shandong Xinhua Pharmaceutical
  • Northeast Pharm
  • Harbin Pharmaceutical
  • LKPC
 
Active Pharmaceutical Ingredients (API) Breakdown Data by Type
 
  • Synthetic APIs
  • Biotech APIs
 
Active Pharmaceutical Ingredients (API) Breakdown Data by Application
 
  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
 
Active Pharmaceutical Ingredients (API) Production Breakdown Data by Region
 
  • United States
  • Europe
  • China
  • Japan
  • Other Regions
 
Active Pharmaceutical Ingredients (API) Consumption Breakdown Data by Region
 
  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Rest of Europe
  • Central & South America
  • Brazil
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa
  • Rest of Middle East & Africa
 
The study objectives are:
 
  • To analyze and research the global Active Pharmaceutical Ingredients (API) capacity, production, value, consumption, status and forecast;
  • To focus on the key Active Pharmaceutical Ingredients (API) manufacturers and study the capacity, production, value, market share and development plans in next few years.
  • To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
 
In this study, the years considered to estimate the market size of Active Pharmaceutical Ingredients (API) :
 
  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
FEATURED COMPANIES
TEVA
Mylan NV
DSM
Aurobindo Pharma
Aspen
Novartis
BASF AG
Pfizer Inc
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
BASF

Table of Contents

 
Global Active Pharmaceutical Ingredients (API) Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications
1 Study Coverage
    1.1 Active Pharmaceutical Ingredients (API) Product
    1.2 Key Market Segments in This Study
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type
        1.4.2 Synthetic APIs
        1.4.3 Biotech APIs
    1.5 Market by Application
        1.5.1 Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application
        1.5.2 CNS
        1.5.3 Cardiovascular
        1.5.4 Genitourinary/Hormonal Drugs
        1.5.5 Respiratory
        1.5.6 Rheumatology
        1.5.7 Diabetes
        1.5.8 Oncology
        1.5.9 Others
    1.6 Study Objectives
    1.7 Years Considered
 
2 Executive Summary
    2.1 Global Active Pharmaceutical Ingredients (API) Production
        2.1.1 Global Active Pharmaceutical Ingredients (API) Revenue 2014-2025
        2.1.2 Global Active Pharmaceutical Ingredients (API) Production 2014-2025
        2.1.3 Global Active Pharmaceutical Ingredients (API) Capacity 2014-2025
        2.1.4 Global Active Pharmaceutical Ingredients (API) Marketing Pricing and Trends
    2.2 Active Pharmaceutical Ingredients (API) Growth Rate (CAGR) 2019-2025
    2.3 Analysis of Competitive Landscape
        2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        2.3.2 Key Active Pharmaceutical Ingredients (API) Manufacturers
    2.4 Market Drivers, Trends and Issues
    2.5 Macroscopic Indicator
        2.5.1 GDP for Major Regions
        2.5.2 Price of Raw Materials in Dollars: Evolution
 
3 Market Size by Manufacturers
    3.1 Active Pharmaceutical Ingredients (API) Production by Manufacturers
        3.1.1 Active Pharmaceutical Ingredients (API) Production by Manufacturers
        3.1.2 Active Pharmaceutical Ingredients (API) Production Market Share by Manufacturers
    3.2 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers
        3.2.1 Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2014-2019)
        3.2.2 Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
    3.3 Active Pharmaceutical Ingredients (API) Price by Manufacturers
    3.4 Mergers & Acquisitions, Expansion Plans
 
4 Active Pharmaceutical Ingredients (API) Production by Regions
    4.1 Global Active Pharmaceutical Ingredients (API) Production by Regions
        4.1.1 Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions
        4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions
    4.2 United States
        4.2.1 United States Active Pharmaceutical Ingredients (API) Production
        4.2.2 United States Active Pharmaceutical Ingredients (API) Revenue
        4.2.3 Key Players in United States
        4.2.4 United States Active Pharmaceutical Ingredients (API) Import & Export
    4.3 Europe
        4.3.1 Europe Active Pharmaceutical Ingredients (API) Production
        4.3.2 Europe Active Pharmaceutical Ingredients (API) Revenue
        4.3.3 Key Players in Europe
        4.3.4 Europe Active Pharmaceutical Ingredients (API) Import & Export
    4.4 China
        4.4.1 China Active Pharmaceutical Ingredients (API) Production
        4.4.2 China Active Pharmaceutical Ingredients (API) Revenue
        4.4.3 Key Players in China
        4.4.4 China Active Pharmaceutical Ingredients (API) Import & Export
    4.5 Japan
        4.5.1 Japan Active Pharmaceutical Ingredients (API) Production
        4.5.2 Japan Active Pharmaceutical Ingredients (API) Revenue
        4.5.3 Key Players in Japan
        4.5.4 Japan Active Pharmaceutical Ingredients (API) Import & Export
    4.6 Other Regions
        4.6.1 South Korea
        4.6.2 India
        4.6.3 Southeast Asia
 
5 Active Pharmaceutical Ingredients (API) Consumption by Regions
    5.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
        5.1.1 Global Active Pharmaceutical Ingredients (API) Consumption by Regions
        5.1.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions
    5.2 North America
        5.2.1 North America Active Pharmaceutical Ingredients (API) Consumption by Application
        5.2.2 North America Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.2.3 United States
        5.2.4 Canada
        5.2.5 Mexico
    5.3 Europe
        5.3.1 Europe Active Pharmaceutical Ingredients (API) Consumption by Application
        5.3.2 Europe Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.3.3 Germany
        5.3.4 France
        5.3.5 UK
        5.3.6 Italy
        5.3.7 Russia
    5.4 Asia Pacific
        5.4.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Application
        5.4.2 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.4.3 China
        5.4.4 Japan
        5.4.5 South Korea
        5.4.6 India
        5.4.7 Australia
        5.4.8 Indonesia
        5.4.9 Thailand
        5.4.10 Malaysia
        5.4.11 Philippines
        5.4.12 Vietnam
    5.5 Central & South America
        5.5.1 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Application
        5.5.2 Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.5.3 Brazil
    5.6 Middle East and Africa
        5.6.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Application
        5.6.2 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Countries
        5.6.3 Turkey
        5.6.4 GCC Countries
        5.6.5 Egypt
        5.6.6 South Africa
 
6 Market Size by Type
    6.1 Global Active Pharmaceutical Ingredients (API) Breakdown Dada by Type
    6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type
    6.3 Active Pharmaceutical Ingredients (API) Price by Type
 
7 Market Size by Application
    7.1 Overview
    7.2 Global Active Pharmaceutical Ingredients (API) Breakdown Dada by Application
        7.2.1 Global Active Pharmaceutical Ingredients (API) Consumption by Application
        7.2.2 Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2014-2019)
 
8 Manufacturers Profiles
    8.1 Teva
        8.1.1 Teva Company Details
        8.1.2 Company Description
        8.1.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.1.4 Active Pharmaceutical Ingredients (API) Product Description
        8.1.5 SWOT Analysis
    8.2 Mylan
        8.2.1 Mylan Company Details
        8.2.2 Company Description
        8.2.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.2.4 Active Pharmaceutical Ingredients (API) Product Description
        8.2.5 SWOT Analysis
    8.3 DSM
        8.3.1 DSM Company Details
        8.3.2 Company Description
        8.3.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.3.4 Active Pharmaceutical Ingredients (API) Product Description
        8.3.5 SWOT Analysis
    8.4 Aurobindo Pharma
        8.4.1 Aurobindo Pharma Company Details
        8.4.2 Company Description
        8.4.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.4.4 Active Pharmaceutical Ingredients (API) Product Description
        8.4.5 SWOT Analysis
    8.5 Aspen
        8.5.1 Aspen Company Details
        8.5.2 Company Description
        8.5.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.5.4 Active Pharmaceutical Ingredients (API) Product Description
        8.5.5 SWOT Analysis
    8.6 Novartis
        8.6.1 Novartis Company Details
        8.6.2 Company Description
        8.6.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.6.4 Active Pharmaceutical Ingredients (API) Product Description
        8.6.5 SWOT Analysis
    8.7 BASF
        8.7.1 BASF Company Details
        8.7.2 Company Description
        8.7.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.7.4 Active Pharmaceutical Ingredients (API) Product Description
        8.7.5 SWOT Analysis
    8.8 Pfizer
        8.8.1 Pfizer Company Details
        8.8.2 Company Description
        8.8.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.8.4 Active Pharmaceutical Ingredients (API) Product Description
        8.8.5 SWOT Analysis
    8.9 Huahai Pharmaceutical
        8.9.1 Huahai Pharmaceutical Company Details
        8.9.2 Company Description
        8.9.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.9.4 Active Pharmaceutical Ingredients (API) Product Description
        8.9.5 SWOT Analysis
    8.10 Hisun Pharmaceutical
        8.10.1 Hisun Pharmaceutical Company Details
        8.10.2 Company Description
        8.10.3 Capacity, Production and Value of Active Pharmaceutical Ingredients (API)
        8.10.4 Active Pharmaceutical Ingredients (API) Product Description
        8.10.5 SWOT Analysis
    8.11 Sun Pharmaceutical Industries
    8.12 Zhejiang Medicine
    8.13 Dr. Reddy’s Laboratories
    8.14 Zhejiang NHU
    8.15 Bayer
    8.16 NCPC
    8.17 AbbVie
    8.18 Shandong Xinhua Pharmaceutical
    8.19 Northeast Pharm
    8.20 Harbin Pharmaceutical
    8.21 LKPC
 
9 Production Forecasts
    9.1 Active Pharmaceutical Ingredients (API) Production and Revenue Forecast
        9.1.1 Global Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025
        9.1.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025
    9.2 Active Pharmaceutical Ingredients (API) Production and Revenue Forecast by Regions
        9.2.1 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions
        9.2.2 Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions
    9.3 Active Pharmaceutical Ingredients (API) Key Producers Forecast
        9.3.1 United States
        9.3.2 Europe
        9.3.3 China
        9.3.4 Japan
    9.4 Forecast by Type
        9.4.1 Global Active Pharmaceutical Ingredients (API) Production Forecast by Type
        9.4.2 Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type
 
10 Consumption Forecast
    10.1 Consumption Forecast by Application
    10.2 Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions
    10.3 North America Market Consumption Forecast
        10.3.1 North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025
        10.3.2 United States
        10.3.3 Canada
        10.3.4 Mexico
    10.4 Europe Market Consumption Forecast
        10.4.1 Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025
        10.4.2 Germany
        10.4.3 France
        10.4.4 UK
        10.4.5 Italy
        10.4.6 Russia
    10.5 Asia Pacific Market Consumption Forecast
        10.5.1 Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025
        10.5.2 China
        10.5.3 Japan
        10.5.4 Korea
        10.5.5 India
        10.5.6 Australia
        10.5.7 Indonesia
        10.5.8 Thailand
        10.5.9 Malaysia
        10.5.10 Philippines
        10.5.11 Vietnam
    10.6 Central & South America Market Consumption Forecast
        10.6.1 Central & South America Active Pharmaceutical Ingredients (API) Consumption Forecast by Country 2019-2025
        10.6.2 Brazil
    10.7 Middle East and Africa Market Consumption Forecast
        10.7.1 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast by Countries 2019-2025
        10.7.2 Middle East and Africa
        10.7.3 Turkey
        10.7.4 GCC Countries
        10.7.5 Egypt
        10.7.6 South Africa
 
11 Upstream, Industry Chain and Downstream Customers Analysis
    11.1 Analysis of Active Pharmaceutical Ingredients (API) Upstream Market
        11.1.1 Active Pharmaceutical Ingredients (API) Key Raw Material
        11.1.2 Typical Suppliers of Key Active Pharmaceutical Ingredients (API) Raw Material
        11.1.3 Active Pharmaceutical Ingredients (API) Raw Material Market Concentration Rate
    11.2 Active Pharmaceutical Ingredients (API) Industry Chain Analysis
    11.3 Marketing & Distribution
    11.4 Active Pharmaceutical Ingredients (API) Distributors
    11.5 Active Pharmaceutical Ingredients (API) Customers
 
12 Opportunities & Challenges, Threat and Affecting Factors
    12.1 Market Opportunities
    12.2 Market Challenges
    12.3 Porter's Five Forces Analysis
 
13 Key Findings
 
14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
        14.1.2 Data Source
    14.2 Author Details
    14.3 Disclaimer
FEATURED COMPANIES
TEVA
Mylan NV
DSM
Aurobindo Pharma
Aspen
Novartis
BASF AG
Pfizer Inc
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy’s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC
BASF

List of Tables and Figures

 
    Figure Active Pharmaceutical Ingredients (API) Product Picture
    Table Active Pharmaceutical Ingredients (API) Key Market Segments in This Study
    Table Key Manufacturers Active Pharmaceutical Ingredients (API) Covered in This Study
    Table Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share 2014-2025
    Figure Synthetic APIs Product Picture
    Table Major Manufacturers of Synthetic APIs
    Figure Biotech APIs Product Picture
    Table Major Manufacturers of Biotech APIs
   Table Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Application 2019-2025 (K MT)
    Figure CNS
    Figure Cardiovascular
    Figure Genitourinary/Hormonal Drugs
    Figure Respiratory
    Figure Rheumatology
    Figure Diabetes
    Figure Oncology
    Figure Others
    Figure Active Pharmaceutical Ingredients (API) Report Years Considered
    Figure Global Active Pharmaceutical Ingredients (API) Revenue 2014-2025 (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Production 2014-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Capacity 2014-2025 (K MT)
    Table Key Manufacturers Active Pharmaceutical Ingredients (API) Capacity (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Price 2014-2025 (USD/MT)
    Table Global Active Pharmaceutical Ingredients (API) Market Size Growth Rate by Regions 2019-2025(K MT) & (Million US$)
    Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Active Pharmaceutical Ingredients (API) Manufacturing Base Distribution and Headquarters
    Table Manufacturers Active Pharmaceutical Ingredients (API) Product Offered
    Table Date of Manufacturers Enter into Active Pharmaceutical Ingredients (API) Market
    Table Global Active Pharmaceutical Ingredients (API) Production by Manufacturers (2014-2019) (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Production Share by Manufacturers in 2018
    Table Active Pharmaceutical Ingredients (API) Revenue by Manufacturers (2014-2019) (Million US$)
    Table Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2014-2019)
    Figure Active Pharmaceutical Ingredients (API) Value Share by Manufacturers in 2018
    Table Active Pharmaceutical Ingredients (API) Price by Manufacturers 2014-2019 (USD/MT)
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Active Pharmaceutical Ingredients (API) Production by Regions 2014-2019 (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share by Regions in 2018
    Table Global Active Pharmaceutical Ingredients (API) Revenue by Regions 2014-2019 (Million US$)
    Table Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Regions in 2018
    Figure United States Active Pharmaceutical Ingredients (API) Production and Growth Rate 2014-2019 (K MT)
    Figure United States Active Pharmaceutical Ingredients (API) Revenue and Growth Rate 2014-2019 (Million US$)
    Table United States Active Pharmaceutical Ingredients (API) Import & Export
    Figure Europe Active Pharmaceutical Ingredients (API) Production and Growth Rate 2014-2019 (K MT)
    Figure Europe Active Pharmaceutical Ingredients (API) Revenue and Growth Rate 2014-2019 (Million US$)
    Table Europe Active Pharmaceutical Ingredients (API) Import & Export
    Figure China Active Pharmaceutical Ingredients (API) Production and Growth Rate 2014-2019 (K MT)
    Figure China Active Pharmaceutical Ingredients (API) Revenue and Growth Rate 2014-2019 (Million US$)
    Table China Active Pharmaceutical Ingredients (API) Import & Export
    Figure Japan Active Pharmaceutical Ingredients (API) Production and Growth Rate 2014-2019 (K MT)
    Figure Japan Active Pharmaceutical Ingredients (API) Revenue and Growth Rate 2014-2019 (Million US$)
    Table Japan Active Pharmaceutical Ingredients (API) Import & Export
    Table Global Active Pharmaceutical Ingredients (API) Consumption by Regions 2014-2019 (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions 2014-2019
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Regions in 2018
    Figure North America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Table North America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Figure 2018 North America Active Pharmaceutical Ingredients (API) Consumption Market Share by Application
    Table North America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
    Figure 2018 North America Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries
    Figure United States Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Canada Active Pharmaceutical Ingredients (API) Consumption (K MT) and Growth Rate (2014-2019)
    Figure Mexico Active Pharmaceutical Ingredients (API) Consumption (K MT) and Growth Rate (2014-2019)
    Figure Europe Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Table Europe Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Figure 2018 Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Application
    Table Europe Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
    Figure 2018 Europe Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries
    Figure Germany Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure France Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure UK Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Italy Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Russia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Asia Pacific Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2014-2019) (K MT)
    Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
    Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries (2014-2019) (K MT)
    Figure China Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Japan Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Korea Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure India Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Australia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Indonesia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Thailand Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Malaysia Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Philippines Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Vietnam Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Central & South America Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (K MT)
    Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Figure 2017 Central & South America Active Pharmaceutical Ingredients (API) Consumption Market Share by Application
    Table Central & South America Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
    Figure Central & South America Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries
    Figure Brazil Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (K MT)
    Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Figure 2018 Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Application
    Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption by Countries (2014-2019) (K MT)
    Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Market Share by Countries
    Figure Turkey Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure GCC Countries Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure Egypt Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Figure South Africa Active Pharmaceutical Ingredients (API) Consumption and Growth Rate (2014-2019) (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Production by Type (2014-2019) (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Production Share by Type (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share by Type (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share by Type in 2018
    Table Global Active Pharmaceutical Ingredients (API) Revenue by Type (2014-2019) (Million US$)
    Table Global Active Pharmaceutical Ingredients (API) Revenue Share by Type (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2018
    Table Active Pharmaceutical Ingredients (API) Price by Type 2014-2019 (USD/MT)
    Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2025) (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Consumption by Application (2014-2019) (K MT)
    Table Global Active Pharmaceutical Ingredients (API) Consumption Share by Application (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share by Application (2014-2019)
    Figure Global Active Pharmaceutical Ingredients (API) Value (Consumption) Market Share by Application (2014-2019)
    Table Teva Company Details
    Table Teva Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Teva Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Teva Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Teva Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Mylan Company Details
    Table Mylan Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Mylan Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Mylan Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Mylan Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table DSM Company Details
    Table DSM Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure DSM Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure DSM Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table DSM Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Aurobindo Pharma Company Details
    Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Aurobindo Pharma Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Aurobindo Pharma Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Aspen Company Details
    Table Aspen Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Aspen Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Aspen Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Aspen Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Novartis Company Details
    Table Novartis Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Novartis Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Novartis Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Novartis Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table BASF Company Details
    Table BASF Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure BASF Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure BASF Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table BASF Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Pfizer Company Details
    Table Pfizer Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Pfizer Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Pfizer Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Pfizer Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Huahai Pharmaceutical Company Details
    Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Hisun Pharmaceutical Company Details
    Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Capacity, Production (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
    Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Growth Rate (2014-2019)
    Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Production Market Share in Global Market
    Table Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) SWOT Analysis
    Table Sun Pharmaceutical Industries Company Details
    Table Zhejiang Medicine Company Details
    Table Dr. Reddy’s Laboratories Company Details
    Table Zhejiang NHU Company Details
    Table Bayer Company Details
    Table NCPC Company Details
    Table AbbVie Company Details
    Table Shandong Xinhua Pharmaceutical Company Details
    Table Northeast Pharm Company Details
    Table Harbin Pharmaceutical Company Details
    Table LKPC Company Details
    Figure Global Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Table Global Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Table Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions 2019-2025 (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Regions 2019-2025 (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Regions 2019-2025
    Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Production Forecast by Regions 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share Forecast by Regions 2019-2025
    Figure United States Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025 (K MT)
    Figure United States Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Figure Europe Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025 (K MT)
    Figure Europe Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Figure China Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025 (K MT)
    Figure China Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Figure Japan Active Pharmaceutical Ingredients (API) Production Forecast 2019-2025 (K MT)
    Figure Japan Active Pharmaceutical Ingredients (API) Revenue Forecast 2019-2025 (Million US$)
    Table Global Active Pharmaceutical Ingredients (API) Production Forecast by Type 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Production Forecast by Type 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Production Market Share Forecast by Type 2019-2025
    Table Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type 2019-2025 (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Forecast by Type 2019-2025 (Million US$)
    Figure Global Active Pharmaceutical Ingredients (API) Revenue Market Share Forecast by Type 2019-2025
    Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Application 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Application 2019-2025
    Table Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure Global Active Pharmaceutical Ingredients (API) Consumption Market Share Forecast by Regions 2019-2025
    Table North America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure United States Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Canada Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure MexicoActive Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Table Europe Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure Germany Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure France Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure UK Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Italy Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Russia Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Table Asia Pacific Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure China Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Japan Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Korea Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure India Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Australia Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Indonesia Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Thailand Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Malaysia Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Philippines Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Vietnam Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Table Central & South America Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure Brazil Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Table Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast by Regions 2019-2025 (K MT)
    Figure Middle East and Africa Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Turkey Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure GCC Countries Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure Egypt Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Figure South Africa Active Pharmaceutical Ingredients (API) Consumption Forecast 2019-2025 (K MT)
    Table Active Pharmaceutical Ingredients (API) Key Raw Material
    Table Typical Suppliers of Key Active Pharmaceutical Ingredients (API) Raw Material
    Figure Active Pharmaceutical Ingredients (API) Industry Chain
    Table Distributors/Traders List
    Table Active Pharmaceutical Ingredients (API) Customers List
    Table Porter’s Five Forces Analysis
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
INQUIRE FOR DISCOUNT
HAVE A QUERY?
INQUIRE ABOUT REPORT EMAIL US
OUR CUSTOMER
Nano Dimension
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Microcarrier Bioreactor Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4O8609
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Immunohistochemistry Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25I8231
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global RNA Analysis & Transcriptomic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2M4266
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global PCR Tubes And PCR Plates Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38E8328
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICIES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions